Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model
2014 ◽
Vol 115
(09)
◽
pp. 554-556
◽
1989 ◽
Vol 43
(5)
◽
pp. 823-827
◽
Keyword(s):
2010 ◽
Vol 64
(12)
◽
pp. 1350-1354
◽
Keyword(s):
2007 ◽
Vol 12
(1)
◽
pp. 330-342
◽
Keyword(s):
2014 ◽
Vol 184
(5)
◽
pp. 1355-1368
◽
2000 ◽
Vol 60
(5)
◽
pp. 687-692
◽